Home › Atherosclerosis › New York › Queens
Atherosclerosis clinical trials in Queens, NY
3 studies for Atherosclerosis are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
RecruitingPhase 2
- DiGiovanna Inst for Med Ed&Res, North Massapequa · 20 mi away
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- NYU Langone Hospital - Long Island, Mineola · 11 mi away
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Laurelton · 5 mi away
- Research Site, Rosedale · 5 mi away
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA9 studies
- Houston, TX7 studies
- Washington, DC7 studies
- Durham, NC6 studies
- Hialeah, FL6 studies
- San Diego, CA5 studies
- Santa Monica, CA5 studies
- Minneapolis, MN5 studies
- Omaha, NE5 studies
- Dallas, TX5 studies
- Memphis, TN5 studies
- Tucson, AZ5 studies
Other studies in Queens
- Breast Cancer67 studies
- Non-Small Cell Lung Cancer49 studies
- Colorectal Cancer33 studies
- Ovarian Cancer30 studies
- Metastatic Cancer28 studies
- Prostate Cancer27 studies
- Endometrial Cancer26 studies
- Cancer (all types)25 studies
- Pancreatic Cancer23 studies
- Lung Cancer22 studies
- Multiple Myeloma19 studies
- Acute Myeloid Leukemia19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.